US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 21.980
  • +0.480+2.23%
Trading Sep 19 11:07 ET
604.38MMarket Cap-7136P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.79%-15.8M
-87.04%-23.94M
-1,375.92%-60.38M
-180.99%-20.97M
-13.09M
-13.52M
-12.8M
24.16%-4.09M
-7.46M
-5.39M
Net income from continuing operations
30.37%-10.25M
-31.40%-16.65M
-547.19%-69.97M
-151.27%-23.69M
---18.88M
---14.73M
---12.67M
-42.95%-10.81M
---9.43M
---7.56M
Operating gains losses
--0
6,443.75%1.05M
-485.71%-123K
-5,280.00%-269K
--106K
--24K
--16K
-102.56%-21K
---5K
--819K
Depreciation and amortization
350.00%18K
66.67%5K
87.50%15K
33.33%4K
--4K
--4K
--3K
300.00%8K
--3K
--2K
Change In working capital
-717.23%-6.2M
-3,018.69%-9.01M
56.52%9.41M
87.30%2.98M
--5.72M
--1M
---289K
421.88%6.01M
--1.59M
--1.15M
-Change in prepaid assets
133.90%119K
-221.60%-518K
136.03%761K
122.64%276K
--410K
---351K
--426K
-13,100.00%-2.11M
---1.22M
---16K
-Change in payables and accrued expense
-467.21%-4.94M
-1,088.11%-8.5M
5.96%8.64M
-3.77%2.7M
--5.31M
--1.35M
---715K
596.84%8.15M
--2.81M
--1.17M
-Change in other current assets
----
----
134.48%10K
--0
--0
----
----
-1,350.00%-29K
--0
---2K
Cash from discontinued investing activities
Operating cash flow
-16.79%-15.8M
-87.04%-23.94M
-1,375.92%-60.38M
-180.99%-20.97M
---13.09M
---13.52M
---12.8M
24.16%-4.09M
---7.46M
---5.39M
Investing cash flow
Cash flow from continuing investing activities
-266.10%-98.39M
300,100.00%18M
-79,956.76%-29.62M
505,866.67%15.17M
-17.91M
-26.88M
-6K
-311.11%-37K
-3K
-9K
Net PPE purchase and sale
-454.17%-133K
--0
18.92%-30K
--0
--0
---24K
---6K
-311.11%-37K
---3K
---9K
Net investment purchase and sale
-265.93%-98.26M
--18M
---29.59M
--15.17M
---17.91M
---26.85M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-266.10%-98.39M
300,100.00%18M
-79,956.76%-29.62M
505,866.67%15.17M
---17.91M
---26.88M
---6K
-311.11%-37K
---3K
---9K
Financing cash flow
Cash flow from continuing financing activities
-2.14M
105.90%171.27M
166.67%80.7M
-109.43%-1.91M
-568K
0
83.18M
32.93%30.26M
20.26M
22.77M
Net common stock issuance
---3.56M
--53.39M
----
----
----
--0
--0
----
----
----
Net preferred stock issuance
--0
--0
175.37%82.98M
--0
--0
--0
--82.98M
32.37%30.13M
--20.24M
--22.77M
Proceeds from stock option exercised by employees
--3.41M
111.82%430K
57.36%203K
--0
--0
--0
--203K
--129K
--15K
--0
Net other financing activities
---1.99M
--117.45M
---2.48M
---1.91M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
---2.14M
105.90%171.27M
166.67%80.7M
-109.43%-1.91M
---568K
--0
--83.18M
32.93%30.26M
--20.26M
--22.77M
Net cash flow
Beginning cash position
74.60%200.47M
-20.93%35.14M
142.75%44.44M
35.37%42.85M
--74.42M
--114.82M
--44.44M
1,837.25%18.31M
--31.65M
--945K
Current changes in cash
-187.93%-116.32M
134.93%165.33M
-135.59%-9.3M
-160.27%-7.71M
---31.57M
---40.4M
--70.38M
50.52%26.13M
--12.79M
--17.36M
End cash Position
13.08%84.15M
74.60%200.47M
-20.93%35.14M
-20.93%35.14M
--42.85M
--74.42M
--114.82M
142.75%44.44M
--44.44M
--18.31M
Free cash flow
-17.57%-15.93M
-86.95%-23.94M
-1,363.42%-60.41M
-180.87%-20.97M
---13.09M
---13.55M
---12.8M
23.60%-4.13M
---7.47M
---5.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
Unqualified Opinion
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.79%-15.8M-87.04%-23.94M-1,375.92%-60.38M-180.99%-20.97M-13.09M-13.52M-12.8M24.16%-4.09M-7.46M-5.39M
Net income from continuing operations 30.37%-10.25M-31.40%-16.65M-547.19%-69.97M-151.27%-23.69M---18.88M---14.73M---12.67M-42.95%-10.81M---9.43M---7.56M
Operating gains losses --06,443.75%1.05M-485.71%-123K-5,280.00%-269K--106K--24K--16K-102.56%-21K---5K--819K
Depreciation and amortization 350.00%18K66.67%5K87.50%15K33.33%4K--4K--4K--3K300.00%8K--3K--2K
Change In working capital -717.23%-6.2M-3,018.69%-9.01M56.52%9.41M87.30%2.98M--5.72M--1M---289K421.88%6.01M--1.59M--1.15M
-Change in prepaid assets 133.90%119K-221.60%-518K136.03%761K122.64%276K--410K---351K--426K-13,100.00%-2.11M---1.22M---16K
-Change in payables and accrued expense -467.21%-4.94M-1,088.11%-8.5M5.96%8.64M-3.77%2.7M--5.31M--1.35M---715K596.84%8.15M--2.81M--1.17M
-Change in other current assets --------134.48%10K--0--0---------1,350.00%-29K--0---2K
Cash from discontinued investing activities
Operating cash flow -16.79%-15.8M-87.04%-23.94M-1,375.92%-60.38M-180.99%-20.97M---13.09M---13.52M---12.8M24.16%-4.09M---7.46M---5.39M
Investing cash flow
Cash flow from continuing investing activities -266.10%-98.39M300,100.00%18M-79,956.76%-29.62M505,866.67%15.17M-17.91M-26.88M-6K-311.11%-37K-3K-9K
Net PPE purchase and sale -454.17%-133K--018.92%-30K--0--0---24K---6K-311.11%-37K---3K---9K
Net investment purchase and sale -265.93%-98.26M--18M---29.59M--15.17M---17.91M---26.85M--0------------
Cash from discontinued investing activities
Investing cash flow -266.10%-98.39M300,100.00%18M-79,956.76%-29.62M505,866.67%15.17M---17.91M---26.88M---6K-311.11%-37K---3K---9K
Financing cash flow
Cash flow from continuing financing activities -2.14M105.90%171.27M166.67%80.7M-109.43%-1.91M-568K083.18M32.93%30.26M20.26M22.77M
Net common stock issuance ---3.56M--53.39M--------------0--0------------
Net preferred stock issuance --0--0175.37%82.98M--0--0--0--82.98M32.37%30.13M--20.24M--22.77M
Proceeds from stock option exercised by employees --3.41M111.82%430K57.36%203K--0--0--0--203K--129K--15K--0
Net other financing activities ---1.99M--117.45M---2.48M---1.91M------------------------
Cash from discontinued financing activities
Financing cash flow ---2.14M105.90%171.27M166.67%80.7M-109.43%-1.91M---568K--0--83.18M32.93%30.26M--20.26M--22.77M
Net cash flow
Beginning cash position 74.60%200.47M-20.93%35.14M142.75%44.44M35.37%42.85M--74.42M--114.82M--44.44M1,837.25%18.31M--31.65M--945K
Current changes in cash -187.93%-116.32M134.93%165.33M-135.59%-9.3M-160.27%-7.71M---31.57M---40.4M--70.38M50.52%26.13M--12.79M--17.36M
End cash Position 13.08%84.15M74.60%200.47M-20.93%35.14M-20.93%35.14M--42.85M--74.42M--114.82M142.75%44.44M--44.44M--18.31M
Free cash flow -17.57%-15.93M-86.95%-23.94M-1,363.42%-60.41M-180.87%-20.97M---13.09M---13.55M---12.8M23.60%-4.13M---7.47M---5.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion--Unqualified Opinion

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data